Chemical Profiling of Primary Mesothelioma Cultures Defines Subtypes with Different Expression Profiles and Clinical Responses by Schunselaar, Laurel M, Quispel-Janssen, Josine M M F, Kim, Yongsoo, Alifrangis, Constantine, Zwart, Wilbert, Baas, Paul, Neefjes, Jacques

Get full text

Comprehensive Pharmacogenomic Profiling of Malignant Pleural Mesothelioma Identifies a Subgroup Sensitive to FGFR Inhibition by Quispel-Janssen, Josine M, Badhai, Jitendra, Schunselaar, Laurel, Price, Stacey, Brammeld, Jonathan, Iorio, Francesco, Kolluri, Krishna, Garnett, Matthew, Berns, Anton, Baas, Paul, McDermott, Ultan, Neefjes, Jacques, Alifrangis, Constantine

Get full text

Programmed Death 1 Blockade With Nivolumab in Patients With Recurrent Malignant Pleural Mesothelioma by Quispel-Janssen, Josine, van der Noort, Vincent, de Vries, Jeltje F., Zimmerman, Marion, Lalezari, Ferry, Thunnissen, Erik, Monkhorst, Kim, Schouten, Robert, Schunselaar, Laurel, Disselhorst, Maria, Klomp, Houke, Hartemink, Koen, Burgers, Sjaak, Buikhuisen, Wieneke, Baas, Paul

Get full text

Nose in malignant mesothelioma—Prediction of response to immune checkpoint inhibitor treatment by Disselhorst, Maria J., de Vries, Rianne, Quispel-Janssen, Josine, Wolf-Lansdorf, Marguerite, Sterk, Peter J., Baas, Paul

Get full text

Immune cells in mesothelioma microenvironment simplistic marker of response to nivolumab plus ipilimumab? by Disselhorst, Maria J., Lubeck, Yoni, van der Noort, Vincent, Quispel-Janssen, Josine, Seignette, Iris M., Sanders, Joyce, Peters, Dennis, Hooijberg, Erik, Baas, Paul

Get full text

OA13.01 A Phase II Study of Nivolumab in Malignant Pleural Mesothelioma (NivoMes): with Translational Research (TR) Biopies by Quispel-Janssen, Josine, Zago, Giulia, Schouten, Robert, Buikhuisen, Wieneke, Monkhorst, Kim, Thunissen, Eric, Baas, Paul

Get full text

Emerging therapies for malignant pleural mesothelioma by Quispel-Janssen, Josine M. M. F., Baas, Paul

Get full text